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Abstract: Gymnema sylvestre R. Br. is one of the most important medicinal plants that grows in tropi-
cal forests in India and South East Asia. Its active ingredients and extracts of leaves and roots are used 
in traditional medicine to treat various ailments and they are present in the market for pharmaceutical 
and parapharmaceutical products. Commercial products based on substances of plant origin that are 
generally connoted as natural have to be subjected to monitoring and evaluation by health authorities 
for their potential impacts on public health. The monitoring and evaluation of these products are criti-
cal because the boundary between a therapeutic action and a functional or healthy activity has not yet been defined in a 
clear and unambiguous way. Therefore, these products are considered borderline products, and they require careful and 
rigorous studies, in order to use them as complement and/or even replacement of synthetic drugs that are characterized by 
side effects and high economic costs. This review explores the traditional uses, chemical composition and biological activ-
ity of G. sylvestre extracts, providing a general framework on the most interesting extracts and what are the necessary 
studies for a complete definition of the range of activities. 
Keywords: Antisweet activity, biological activity, functional foods, Gymnema sylvestre, gymnemic acid, phytochemical inves-
tigation, traditional uses.  
1. INTRODUCTION 
 In recent years, interest in the biological activity of natu-
rally occurring substances has grown steadily. In fact, it is 
well known that there has been an increase in the use of food 
supplements and various substances based on natural prod-
ucts [1-5], which are often neither standardized nor thor-
oughly studied with respect to their possible beneficial or 
adverse consequences. This invokes the need for careful and 
rigorous studies of natural substances, with the aim of using 
them to complement and/or even replace synthetic drugs that 
are characterized by side effects [6] and high economic costs 
[7]. Moreover, the progressive shortage of antimicrobial 
drugs coupled with the associated and growing drug resis-
tance [8] requires new treatments that are easily prescribed, 
cost effective, and thus from natural sources. Therefore the 
full attention of researchers should be devoted to rigorous 
experimental studies of such substances [9]. 
 When we discuss plant drugs, we refer to the plant or part 
of the plant that is used medicinally (roots, leaves, seeds, 
bark, etc.). These plants contain chemical compounds that 
are likely to have ‘pharmacological action’ (active ingredients), 
as well as substances of no or little practical interest. In the 
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world of natural substances there are thousands of drugs that 
are found singly or in mixtures, which are used as comple-
ments or as alternatives to conventional therapies [10-12] or 
even for non-medical purposes [13, 14]. Complementary 
medicine includes all health care practices that are not part of 
the tradition of a country. Traditional medicine represents the 
body of knowledge, practices, methods, and beliefs of differ-
ent populations, based on observations and experiences that 
are passed on from generation to generation and used to pre-
vent and eliminate imbalances in the physical, mental and 
social well-being of individuals [15]. 
 Plants used as a complementary or alternative treatment 
have been and continue to be the subject of studies for the 
detection of single molecules or phytocomplexes with thera-
peutic activities. In fact, while their traditional uses are valid, 
the knowledge of these plants is not sufficient for them to be 
used safely in modern medicine. However, through phyto-
chemical and biological screening, we aim to determine if 
these plants can be used with positive, practical and safe 
therapeutic results. Knowledge of the therapeutic properties 
of many plants used in traditional medicine has been handed 
down since the beginning of civilization and these plants 
have been used as healing herbs on the basis of observations. 
 With the introduction of new techniques for the isolation 
and chemical synthesis of biologically active molecules, the 
scientific world has been moving towards synthetic products. 
This change has been driven by several factors, such as the 
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difficulty in finding new plant sources, the slow processes of 
extraction and, last but not the least, the high cost of this 
approach. However, in the last decades of the twentieth cen-
tury there was a resurgence in plant interest, which was ap-
preciated by a growing number of consumers who chose to 
return to nature for disease prevention and general health 
care. Most of the world population currently prefers tradi-
tional herbal medicine [16].  
 Since the 1990s, the WHO has aroused interest in tradi-
tional medicine in developing countries and has stimulated 
studies of the medicinal plants used in these areas to give 
scientific value to the empirical practice so that their use can 
be justified for primary care [17-19]. 
 The monitoring and evaluation of natural substances are 
critical because the boundary between a therapeutic action 
and a functional or healthy activity has not yet been defined 
in a clear and unambiguous way. Therefore, these products 
are considered borderline products. The categories that in-
clude products of natural origin are represented by: medici-
nal products, food supplements, cosmetics and medical de-
vices. There is a great deal of interest in products of plant 
origin in each of the respective industries. Areas of further 
application development are those represented by veterinary, 
cosmetic and homeopathic products. Research in the field of 
natural substances should aim to demonstrate the effective 
use of direct plant products (extracts or infusions), in therapy 
or foodstuffs. In general, we used two types of approach to 
study the activity of natural active substances: to characterize 
the single active substance or to study a natural extract in its 
entirety. 
 In the first case, it is necessary to achieve the isolation 
and characterization of each single molecule, the active in-
gredient(s),that often prove to be less active in isolation than 
in the original mixture [20-22].  
 The alternative to this approach is to study the activity of 
the plant complex in its entirety. 
 One approach is not superior to the other, they are just 
different. The common aim is to identify a medicinal sub-
stance or mixture that possesses curative activity and is safe 
with regard to adverse events. 
 Many single molecules with high degrees of purity are 
well known to be useful in emergencies and in serious clini-
cal situations in which there is the need for effective and 
fast-acting pharmacological intervention, for example, 
adrenaline, cardiotonics, antiarrhythmics, antihistamines, 
antibiotics, etc. Many of these drugs are semisynthetic de-
rivatives of natural substances [23]. The plant world repre-
sents the most important reservoir of substances with phar-
macological activity [24]. For plant-derived materials, it is 
important to emphasize the concept of phytocomplexes. A 
phytocomplex can be defined as an ensemble of individual 
molecules with specific activities present in a plant that is 
associated with other constituents that do not have clear 
pharmacological activities, but most likely support the active 
molecules. It seems that the harmonious and synergistic 
presence of all the substances in a phytocomplex is responsi-
ble for the therapeutic activity of the drug plant in its entirety 
[25]. 
 Herbal remedies can be used to treat mental and physical 
fatigue, some endocrine imbalances, liver failure, constipa-
tion, high cholesterol, and venous insufficiency, to give just 
a few examples. 
 Therapeutic products on the market today are often the 
result of a compromise between tradition and market demand 
[26]. A natural source can possess a variety of therapeutic 
properties, which must be supported by clinical findings. In 
other words, these properties must be scientifically demon-
strated. Each plant source must be studied chemically and 
tested in the clinic. In addition, each source typically under-
goes transformations that reflect the specific ways that the 
source will be clinically applied in the culture in which it 
will be marketed. 
2. ISOLATION AND CONTENT DETERMINATION 
OF GYMNEMIC ACID  
 G. sylvestre (GS), one of the most powerful medicinal 
plants [27], is a perennial, woody climber, spread through 
India and South East Asia, in dry forests up to 600 m height. 
The plant is large, with opposite leaves, usually elliptic or 
ovate, and small, yellow flowers. This plant is used in tradi-
tional medicine to treat various ailments, especially in India 
[28]. For example, the leaves are rubbed on infected body 
parts to cure infections and chewed to suppress the taste for 
sweet and bitter substances. It is also used in decoctions to 
cure diabetes and stress-related disorders and is prescribed to 
treat urinary problems and stomach-ache. Additionally, the 
leaf extract is applied to treat cornea opacity and other eye 
diseases. It is used in glycosuria to remove bad odours from 
breast milk and as an aperitive. Ayurveda states that it is 
acrid and bitter, digestive and diuretic, anthelmintic and 
laxative, vomitive, expectorant, stimulant, analgesic, antipy-
retic and cardiotonic. Furthemore, the leaf extract is tradi-
tionally used in treating conjunctivitis, jaundice and leu-
coderma, hepatosplenomegaly, amenorrhoea and haemor-
rhoids. The root extract is emetic and used in treating insect 
bites [27, 28]. In traditional Indian medicine, similarly to 
other traditional medicine practices, the only part of the plant 
that is typically used is the leaf. Thus, it is no wonder that 
most of the articles cited in the literature report the isolation 
of a saponin-rich fraction from the leaves of GS, using a sol-
vent such as ethanol that is pure or has a water content of 
less than 25-30% (however, in some cases pure water is used 
on the whole plant). The isolation and characterization of the 
saponin-rich fraction from indigenous GS leaves was con-
ducted with different methods of extraction to optimize the 
maximum yield. Different parameters such as the concentra-
tion of ethanol (70%), the ratio of plant/liquid (1:6), extrac-
tion time (3 h), and extraction frequency (twice), were estab-
lished to obtain the optimum extraction process by infusion 
[29]. Alternatively, the defatted leaves were extracted under 
continuous hot extraction in a Soxhlet apparatus with 95% 
ethanol resulting in the maximum yield of gymnemic acid 
(6.2%). Moreover, the minimum yield obtained was with 
aqueous extraction (1.7%). We also used microwave-assisted 
and releasing-inner ebullition extraction technology, with an 
extraction time of 8 min, microwave power of 250 W, etha-
nol concentration of 60%, and solid-solvent ratio of 1:10 [30, 
31]. Under the above conditions, the total saponins extrac-
tion yield was 98%. When compared to traditional extraction 
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methods, the microwave-assisted extraction was faster to 
operate, gave a higher yield and consumed less solvent. By 
adding water to the alcoholic extract of the leaves, a green 
soft precipitate was obtained which melted at 68 °C and 
composed of approximately 0.05% of the leaf material. 
Hooper named gymnemic acid the dark-coloured complex 
mixture that was obtained from this precipitate with the addi-
tion of sulphuric acid [32]. Its soluble extract in ethyl acetate 
temporarily destroyed the sense of taste for sweet substances. 
This organic extract was in its turn a mixture of substances, 
weakly acidic, amounting to approximately 6% of the air-
dried leaves then called gymnemic acid (GA) (Table 1) [33, 
34]. In general GA is accompanied by a large number of 
products of different chemical natures and polarities (for 
example stigmasterol, α-amyrin, β-amyrin and lupeol ace-
tate). Some protocols have been developed for the partial 
purification of this fraction as well as for its enrichment in 
saponins or gymnemic acids and derivatives. The crude 
gymnemic acid extract (GAE), was separated by affinity 
chromatography using γ-cyclodextrin as a ligand [35] and 
enriched with macroporous resins [36]. In particular, the 
adsorption capacities and adsorption ratios of five types of 
adsorption resins for the total saponins content were investi-
gated. The concentration and pH of saponins in solution, 
flow rate and concentration of the elution reagent were opti-
mized using these resins. The results demonstrated that the 
purity of total saponins increased from 25% to 51% with a 
recovery of 83%. Next the impurities were eluted with dis-
tilled water and 10% ethanol. The adsorbed total saponins 
were eluted with 50% ethanol. The purity of the resulting 
total saponins was 56%. Additionally, there is a patent re-
garding the use of a reverse osmosis membrane with differ-
ent solvents to obtain a sterile filtrate without a bitter taste. 
The saponin content can be determined spectrophotometri-
cally [37] or by chemiluminescence [38]. When GA was 
treated with a mixture of vanillin-glacial acetic acid and per-
chlorate, it displayed the same colour with a maximum ab-
sorption at 545 nm [37]. The linear range was between 40-
160 µg, and the method is fast, simple and convenient, and 
has a high accuracy and stability. 
3. PHYTOCHEMICAL ANALYSIS OF EXTRACTS OF 
G. SYLVESTRE R. BR.  
 Several classes of substances, including steroids, sapon-
ins, alkaloids, terpenoids, amino acids, flavonoids, phenolics 
and essential oils, were the most abundant phytochemicals 
present in the stem and leaf samples of Gymnema, as shown 
by standard methods that were used for preliminary phyto-
chemical screening of the extracts (Table 2) [42]. 
 The less polar extract, that was obtained by petrol ether 
and contained reducing sugars, terpenoids (including a large 
quantity of limonene), saturated and unsaturated fatty acids 
(such as hexadecanoic acid ethyl ester), phenolic com-
pounds, hydrocarbons (such as undecane), and saponins [42, 
43]. The benzene extract contained reducing sugars, terpe-
noids and tannins [42]. The chloroform extract contained 
reducing sugars, tannins, alkaloids (such as 2-
isopropylpiperazine), hydrocarbons (such as tridecane), al-
dehydes (such as butanal), and saturated and unsaturated 
fatty acids (such as 9-octadecenoic acid) [42-44]. The ethyl 
acetate extract contained reducing sugars, flavonoids and 
saponins [42], while the ethanol [45] and methanol extracts 
[42, 45] contained reducing sugars, terpenoids and tannins; 
the distilled water extract contained reducing sugars, terpe-
noids, flavonoids and tannins [42, 45]. Therefore the leaf 
extract showed moderate concentrations of flavonoids, phe-
nols, saponins, sterols, tannins while the stem extract con-
tained terpenoids, flavonoids, phenols, saponins and sterols 
[44]. The quality and purity of dry drugs were established by 
evaluating the ash values. According to Ayurvedic Pharma-
copeia [46], the amount of ash in GS should not exceed 12%. 
4. PHARMACOGNOSTIC ACTIVITIES OF GYMNE-
MIC ACID AND DIFFERENT EXTRACTS OF G. 
SYLVESTRE  
 GS has its own chemical composition and includes a 
large number of chemicals, most of which have their own 
obvious and known therapeutic activity, while others are 
considered secondary and some are inert [27-28]. All chemi-
cals, including those that are active and inert, form what is
Table 1. Isolation and content determination of Gymnemic acid. 
Analysis Part of the plant Extract Ref. 
Ethanol [29, 33, 34] 
Ethanol after defatting 
Acidic and neutral fractions of ethanol 
Ethanol without defatting 
[33] Leaves 
Extraction by microwave [30, 31] 
Isolation of saponin fraction (SF) 
Whole plant Water [33] 
Determination of total saponins Leaves - [37, 38] 
Enrichment of SF - - [36, 39, 40] 
Partial purification of SF Leaves Water [35, 41] 
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Fig. (1). Structure of the main saponins present in the stem and leaf samples of Gymnema. 
 
Table 2. Phytochemical analyses of different extracts. 
Study/Analysis Part of the plant Extract Ref. 
Whole plant 
Water, methanol, ethyl acetate, chloroform, 
benzene, petrol ether 
[42] 
Aerial parts Water, methanol and ethanol [45] 
Methanol [43, 44, 46] 
Acetone [44] 
Chloroform [43, 44] 
Phytochemical analyses (qualitative analysis and 
quantitative estimation of flavonoids, hydrolysable 
tannins, phenols, saponins, sterols and terpenoids) 
 
Petrol ether [43] 
 
called a phytocomplex. The action of a phytocomplex may 
have therapeutic properties that are different from those of 
one or more of its components taken individually. In com-
parison to the action of the active principles, phytocomplexes 
are slower acting, but in conjugation with the active princi-
ples, the total action is more complete and less toxic.  
4.1. Sweetness-inhibiting Effects  
 The leaves of GS (1 cm2), when chewed for 1-2 min, 
temporarily depress sensitivity to sweet and bitter substances 
[47, 48], and it has been demonstrated that gymnemic acid 
can completely block the perception of a sweet taste. Nu-
merous studies reported the sweetness-inhibiting effects of 
GS extracts, in particular reducing by an average of 77% the 
perception of different concentrations of synthetic sweeten-
ers such as acesulfame K, aspartame, sodium cyclamate, and 
of natural sweeteners such as fructose, glucose, sucrose, 
stevioside and xylitol [47]. The percentage reduction in 
sweetness was constant across low, medium and high con-
centrations of the sweeteners. The effects of GS extract 
(GSE), and purified GA were also studied on the taste of 
glycine and DL-alanine. GSE produced the expected depres-
sion of tasting sweetness due to the two amino acids and 
depressions and enhancements for sour, salty and bitter stim-
uli [49], while the full sweetness-inhibiting effect of GA 
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appeared after 30 sec and was recovered no earlier than  
50 min. 
4.2. Hypoglycaemic and Antihyperglycaemic Effects 
 Hyperglycaemia, an abnormally high blood glucose level, 
is a hallmark sign of diabetes and its pathophysiology is very 
complicated and affected by many parameters such as food 
intake and exercise. Over time, hyperglycaemia can cause 
microvascular and macrovascular problems, requiring its 
control in diabetic patients. Although various conventional 
therapies for diabetes are available on the market, they have 
many shortcomings, including side effects and high rates of 
failure. However, herbal extracts are expected to have simi-
lar efficacy as with conventional drugs, but without side ef-
fects. Various studies present in the literature have reported 
the use of GS extracts in different diabetic models, but the 
most effective and safest extract for human consumption has 
not been determined. The water, ethanol, methanol, hexane 
and chloroform extracts of GS were investigated on rats for 
their hypoglycaemic and antihyperglycaemic potentials [50-
52]. In particular, the ethanol extract exhibited the highest 
hypoglycaemic and antihyperglycaemic potentials (46% and 
36%, respectively) [53], while the water extract was less 
active, reducing the blood glucose levels by 26%, and the 
methanol extract moderately reduced it only by 12% [50, 53-
57]. No significant effects were observed in blood glucose 
values ingesting the hexane or chloroform extracts. It may be 
affirmed that the ethanol extract of GS leaves has higher hy-
poglycaemic and antihyperglycaemic potential and should be 
used as a complementary medicine to treat the diabetic pa-
tients by significantly reducing the use of standard drugs. 
The effect of gymnemic acid (0.4 g/kg of body weight), on 
the elevation of blood glucose was evaluated in normal sub-
jects after sucrose intake (6 g/kg of body weight). In the con-
trol group, the fasting blood glucose level (101 mg/dL), was 
rapidly elevated to 145 mg/dL (44% increase), at 15 min and 
reached a maximum of 148 mg/dL (47% increase), at 30 min 
after sucrose administration. Blood glucose levels returned to 
the basal level after 120 min. In group 1, where GA was ad-
ministered simultaneously with sucrose, the glucose level 
increased by 23% after 15 min and 33% after 30 min of su-
crose administration. The per cent increase in blood glucose 
level was suppressed to 53 and 68% of the control group at 
15 and 30 min after sucrose administration, respectively. 
Even better results were obtained for group 2, where GA was 
administered at 2 h and 1 h before sucrose and simultane-
ously with sucrose. The glucose level increased to 13% at 15 
min and 20% at 30 min after sucrose administration. The 
percentages decreased by 31 and 41% when compared to the 
control group and by 58 and 60% compared to group 1. 
These results were confirmed by a study where GA showed 
dose-dependent hypoglycaemic effects in rats with streptozo-
tocin-induced diabetes mellitus that were loaded orally with 
4 g sucrose/kg and 1 to 4 doses of 400 ng gymnemic acid/kg. 
The results suggest that GA has a suppressive effect on 
blood glucose levels after sucrose administration.  
 Thus, GA may have an application in the therapy or pre-
vention of diabetes mellitus and obesity [51, 52]. The high 
K+-induced contraction of guinea pig ileal longitudinal mus-
cles and the transmural potential difference in the inverted 
intestines are the results of inhibition of glucose uptake in 
the intestines, due to GA and GSE of the leaves, coupled to 
Na+ transport processes. 
4.3. Gastric Inhibitory Peptide Release Effect  
 The leaf extracts of GS and purified GA were assayed to 
evaluate their effects on the increase of Gastric Inhibitory 
Peptide (GIP), released into the portal vein in response to a 
duodenal infusion of D-glucose, showing that the increase of 
GIP was significantly depressed [58]. As GA does not inhibit 
sweet taste perception in rats, and gurmarin, one of the active 
components of Gymnema leaf extract, does not have any 
effect on GIP release, this means that not necessarily is the 
glucose receptor for GIP release identical to the receptor for 
sweet taste detection. On the other hand, Yoshioka [59] re-
ported that an extract of GS leaves and GA inhibited active 
transport of glucose in rats, showing that the observed inhibi-
tion of GIP release by GA could be due to its interaction 
with the glucose receptor for GIP release, which is similar to 
the active glucose transport system. These results suggest 
that a glucose receptor interacts with the leaf extracts of GS 
and purified GA, resulting in the release of immunoreactive 
GIP and that the glucose receptor for GIP release is not 
likely to be identical to a glucose transporter. 
4.4. Gymnemic Acids and Cholesterol Metabolism 
 The effect of gymnemic acid on cholesterol metabolism 
has not been clarified yet. The crude extract from GS leaves, 
the gymnemic acid and a gymnemagenin-rich fraction 
(GSF), were tested at various concentrations on rats, admin-
istering them orally doses of 0.05-1.0 g/kg for 22 days [60]. 
No significant differences were noted in the faecal excretion 
of rats dosed with GSE, GA or GSF. Body weight and food 
intakes decreased with the assumption of GSA and GSF, 
while GSF increased the faecal content of cholesterol, co-
prostanol (intestinal metabolite of cholesterol), total neutral 
steroids and bile acids, in a dose-dependent manner. Fur-
thermore, the administration of GA caused the hypertrophy 
of the stomach wall, suggesting that gymnemic acids irritate 
 
 
Fig. (2). A general schematic representation of competitive inhibition of receptor site by Gymnemic acid. 
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the epithelium of the gastrointestinal tract, and in contrast, in 
animals fed a high cholesterol diet, it decreased serum and 
hepatic cholesterol.  
4.5. Anti-arthritic Activity 
 The leaf extracts of GS were assayed to evaluate their 
anti-arthritic activity using rats and diclofenac sodium as a 
standard drug. Among the different extracts analysed, the 
petroleum ether and aqueous extracts possessed the highest 
anti-arthritic activity in relation to all parameters considered 
[61]. 
4.6. Antimicrobial Activity  
 GS has been analysed for antimicrobial activity, in par-
ticular both crude and pure saponins fractions [45]. The pure 
saponin fraction was more active than the crude one and was 
comparable to the activity of chloramphenicol. The gram-
negative bacterium Pseudomonas aeruginosa was more sus-
ceptible to saponins than Staphylococcus aureus, Es-
cherichia coli, Salmonella typhi, Proteus mirabilis, and 
Klebsiella pneumonia [62]. Extracts with different solvents 
of the whole GS or of different parts of it were screened for 
their antimicrobial activity using the agar well diffusion 
method against Streptococcus mutans, S. aureus, Streptococ-
cus mitis and Candida albicans with doses ranging between 
25 and 100 mg/mL. The methanol extract showed the 
strongest antimicrobial activity. The crude ethanolic extract 
of GS leaves possesses a significant antibacterial activity 
against Bacillus pumilis, B. subtilis, P. aeruginosa and S. 
aureus. The chloroform extracts of the aerial and root parts 
were more active than the diethyl ether and acetone ones [63, 
64], in particular the root chloroform extract exhibited com-
petitive minimum inhibitory concentration and minimum 
bactericidal concentration values in the range of 0.04-1.28 
mg/mL and 0.08-2.56 mg/mL, respectively [65]. Finally, the 
hexane extract showed maximum inhibition against Serratia 
marcescens MTCC [66]. 
4.7. Antifungal Activity 
 The crude and pure saponin fractions from the leaves of 
GS showed significant antifungal activity, up to 3-fold 
greater than the activity of the standard drug amphotericin B. 
Aspergillus fumigatus was inhibited more than Aspergillus 
flavus and Aspergillus niger, and [67]. It seems to prove that 
the antimicrobial activity of plant extracts is due to the pres-
ence of saponins and that the minimum inhibitory concentra-
tion values ranged from 600 to 1,200 mg/L. Saponins may be 
used in the future as preventive and therapeutic agents 
against Gram-negative bacteria and fungi. 
4.8. Larvicidal Effect 
 Several plants showed mosquitocidal activity, but few of 
them have been characterized from a chemical point of view 
and even less of those that have moved from the laboratory 
to field use. Insecticides of natural origin may be a viable 
alternative to those of synthesis, given that more and more 
insects are resistant to them. 
 GS seems to be useful to control the population of Culex 
tritaeniorhynchus [44], as demonstrated by the efficacy of its 
acetone, chloroform and methanol crude extracts. The larv-
icidal effect of the plant extract was clearly dependent on the 
concentrations of each extract. No mortality was observed in 
the control batch larvae maintained in the control medium 
for 24 h. The experimental larvae were more susceptible to 
the maximum concentration and the maximum larval mortal-
ity of 100.00% was observed with 100 ppm concentration of 
the acetone and methanol extracts, and 6.9, 10.5 and 15.4% 
larval mortality was observed for the acetone, chloroform 
and methanol crude extracts, respectively, at 6.25 ppm. The 
extracts or isolated pure compounds could be used in stag-
nant water bodies, to prevent mosquitoes laying and hatching 
eggs [68]. 
4.9. Total Phenolic Content and in vitro Antioxidant Ac-
tivity 
 The methanolic extract of GS leaves was analyzed to 
evaluate the total phenolic content and in vitro antioxidant 
activity using DPPH, hydroxyl radical, nitric oxide radical 
scavenging and ferric reducing power assays [38, 45, 46]. 
The total phenolic content of the extract was 2.2 µg/mg of 
catechol equivalent. The IC50 values for the DPPH, hydroxyl 
radical and nitric oxide radical scavenging assays were 450, 
625 and 1,724 µg/mL, respectively. In the ferric reducing 
power assay, the methanolic extract of GS showed an absor-
bance of 0.13 at 500 µg/mL. The extract showed significant 
activity due to the presence of phenolic compounds such as 
flavonoids, tannins and saponins in a concentration-
dependent manner.  
 Rats with diabetes after administration of streptozotocin 
and a herbo-mineral formulation containing gymnemic acid, 
showed a significant decrease in blood glucose and urea ni-
trogen, glycosylated haemoglobin, creatinine, triglycerides, 
total cholesterol, serum albumin, as well as albumin and 
creatinine excretion rate [54]. Altered levels of antioxidants 
like glutathione and superoxide dismutase were restored in 
the kidney. The experimental results clearly demonstrate that 
gymnemic acids, which possess potent antioxidant proper-
ties, have the ability to prevent the progression of early dia-
betic nephropathy. These results suggest that the extract may 
act as a natural antioxidant agent with health benefits. 
4.10. Inhibitory Effects on Breast Cancer Resistance Pro-
tein 
 The ethanolic extract of GS leaves containing 10.5% 
gymnemic acid strongly inhibited Breast Cancer Resistance 
Protein (BCRP)-mediated methotrexate (MTX) at 1 mg/mL. 
BCRP is an efflux transporter expressed in intestinal epithe-
lial cells, as well as the bile canaliculus, kidney, blood-brain 
barrier and placenta, and its inhibition increases the systemic 
availability of various drugs, including methotrexate, topoi-
somerase I inhibitors, flavopiridol, statins and proton pump 
inhibitors [69]. 
4.11. Use as a Weight Loss Aid 
 A diet with a high content of gymnemic acids can be a 
valuable aid for the control of body weight. In fact, GA can 
inhibit oleic acid absorption, as demonstrated by studying the 
effects of its use in the diet of Otsuka Long-Evans Toku-
shima Fatty (OLETF) rats, which are obese animal models 
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with type II diabetes [70, 71]. The studies showed a decrease 
of feed and water intake (approximately 1/3 and 2/3, respec-
tively), along with body weight. At the end of the experi-
ment, the total cholesterol level decreased by approximately 
1/3 and LDL + VLDL cholesterol decreased by approxi-
mately 1/2. The blood serum triglyceride level decreased to 
1/4 of the OLETF control [72]. Moreover, the results demon-
strated that the inhibition by GA was dose-dependent and 
reversible and that the extent of inhibition and the recovery 
progress were comparable to that of glucose absorption. 
Thus, GA promoted body weight loss by its ability to de-
crease hyperlipidaemia and showed no withdrawal rebound 
effects on body weight [73]. 
4.12. Treatment of Dental Caries 
 The formation and progression of dental caries are 
closely associated to the presence of different types of Gram-
positive bacteria. Primary cariogenic bacteria such as S. mu-
tans, S. aureus, S. mitis and the fungus C. albicans form den-
tal plaques that adhere to tooth surfaces through the synthesis 
of extracellular polysaccharides. Then these bacteria metabo-
lise sugars to organic acids, which are responsible for the 
demineralisation of tooth enamel. It is therefore clear the 
need to eliminate the cariogenic bacteria from the oral cavity 
but keeping in mind that many of these are moderately resis-
tant to antibiotics such as chloramphenicol, clindamycin, and 
ampicillin. A viable alternative to antibiotics, which are ex-
pensive and have side effects such as gastrointestinal prob-
lems, would be the use of plants whose extracts are tradition-
ally used for dental hygiene thanks to their powerful antibac-
terial activity. Among them is GS. The effects of various 
extracts of GS in preventing dental caries have been assayed 
[39] and the methanol extract showed the strongest antimi-
crobial activity [43]. But also other extracts of GS were 
screened for their particle size and total microbial load, 
among them the hydro alcoholic extract. This latter one is 
used in some toothpastes with acceptable findings with re-
spect to efficacy, economic costs, and accessibility [43], con-
firming the validity of the choice of using natural extracts in 
treating dental caries. 
4.13. G. sylvestre in Functional Foods 
 Currently, GS extracts can be used to produce a series of 
products as functional foods. Normally GS ethanol extract or 
extracts of other plants are used to produce functional foods 
containing a percentage of GS between the 30 and 80%, with 
a triterpenoid saponin content of 20-70%, and minor quanti-
ties of alkaloids, glycosides and anthraquinones [74]. The 
crude mixture is filtered, the ethanol is recovered, a de-
foamer and adjuvants are added, the extract is dried and pul-
verised and then added into capsules or formed into granules 
or pellets. Using this method, the effectiveness of compo-
nents of herbal drugs can be extended by emulsification, 
which is induced by the triterpenoid saponins in water and 
the low concentration of ethanol [75]. The extract can be 
used to prepare medicines and health foods with applications 
in decreasing waist circumference, body weight, obesity in-
dex [76, 77], blood pressure, blood sugar [78-80], and blood 
lipids, or to inhibit the excessive sweetness of moon cake, 
chocolate, ice cream, etc. for blood sugar control in diabetes 
[81]. 
4.14. Effect on Rumen Methanogenesis 
 About 10% of what ruminants eat is lost or wasted for the 
production of methane, a greenhouse gas 23 times more po-
tent than carbon dioxide [82]. Therefore, to lower this per-
centage would mean to improve the efficiency of nutrient 
utilisation and to make farms more sustainable from an envi-
ronmental perspective. Once again, the plants can help us, 
providing compounds to mitigate rumen methanogenesis. 
Saponins (or tannins) suppress or eliminate protozoa from 
the rumen and reduce methane and ammonia production. 
 When GS is used as an additive in ruminant feeds it has 
the potential to suppress methanogenesis, because of the 
presence of saponins and essential oils, without causing sub-
stantial modifications in fermentation parameters [82]. The 
studies suggest that this material does not affect substrate 
degradation and is not toxic to ruminal microbes.  
5. CONCLUSION 
 GS is a plant that grows primarily in tropical forests in 
India and Southeast Asia. The active ingredients of the plant 
are found in the leaves and roots, which are used in Ayurve-
dic medicine. For over two thousand years, the leaves of GS 
have been used in the Far East, in particular in India, for the 
treatment of diabetes. In India this plant is also used to treat 
snakebites and to relieve intestinal disorders, diseases of the 
liver and the cold. Indian doctors recommend the use of GS 
as an additive for the treatment of obesity and tooth decay. 
Its use is more prevalent in India, but the GS plant has also 
been exploited for its numerous properties in Australia, Viet-
nam and Japan. An active principle that is located in the 
leaves and roots of GS is a mixture of gymnemic acids, 
which are capable of binding to intestinal receptors that have 
the task of absorbing sucrose, thus causing a reversible block 
in sugar absorption and leaving low the blood glucose level. 
These properties suggest that GS is indicated for use in cases 
of alimentary hyperglycaemia, or a high sugar intake, or in 
cases of diabetes. The ability of GS to inhibit the absorption 
of sugars and encourage disposal, make GS a great aid for 
those who are overweight and want to lose weight, provided 
that the excess weight is due to a diet rich in simple sugars 
and sweets of various types, including potatoes, bread, and 
pasta. 
 In addition to limiting blood sugar levels, the GS plant 
also has the effect of nullifying sweet tastes. A small amount 
of GS, placed on the tongue, is able to decrease the sweet 
taste, leaving unchanged the taste towards bitter, salty and 
sour substances. This effect can be useful for those who want 
to fight the desire to consume sweet foods by cancelling the 
prevailing taste so that they are less attractive. In addition to 
considerably lowering the absorption of sugar, GS is also 
able to reduce the level of lipids in the blood. It is a plant 
whose use is suggested for those who suffer from a high 
concentration of triglycerides and of so-called bad choles-
terol in the blood because it considerably reduces the quan-
tity of both. GS can even be used to treat cases of water re-
tention as it is recognized as having a mild diuretic effect. 
Other extensive uses of GS include as a treatment for stom-
ach disorders, diseases of the liver and cases of constipation. 
If that was not enough, GS has been used successfully for the 
treatment of gout and rheumatoid arthritis. Finally, the leaves
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Table 3. Biological activities of different extracts. 
Entry Study/Analysis Part of the plant Extract Ref. 
A Effects of the sour, salty, bitter and sweet suppressant / / [47-49] 
- - [50] 
- Ethanol 75% [53] 
Whole plant Water [54, 57] 
Water [51] 
Methanol 
Ethanol 
Chloroform 
B 
Suppression of glucose absorption. 
Hypoglycemic and antihyperglycemic activity 
Leaves 
Hexane 
[52] 
C Effect on glucose-stimulated gastric inhibitory peptide secretion Leaves Water gymnemic acid [58] 
D Anti-arthritic activity Leaves - [61] 
Whole plant Hexane [66] 
Aerial parts Acetone, chloroform, diethylether [63] 
Water, methanol, ethanol,  
methanol, chloroform, petrol ether 
[45] 
Leaves 
Pure saponin fraction [67] 
E Antibacterial activity in vitro condition 
Roots Acetone, chloroform, diethylether [63] 
F Antifungal activity in vitro condition 
Leaves 
 
Pure saponin fraction [67] 
G Larvicidal activity Leaves Methanol, acetone chloroform 
[68] 
[44] 
Whole plant Water [54] 
Aerial parts Water, methanol [45] 
Leaves Ethanol, methanol [46] 
H Antioxidant activity 
- - [38] 
I Inhibitory effects on breast cancer resistance protein Leaves Ethanol [69] 
L Antiobesity effect Leaves Saponin-rich fraction [72, 82] 
M Effect on transdermal delivery of aceclofenac Whole plant Methanol [55, 56] 
N Effects on fecal steroid excretion - Saponin-rich fraction [60] 
O Protective effect on early diabetic nephropathy Leaves Methanol [83] 
P Inhibitory effect on intestinal absorption of oleic acid Leaves - [70, 71] 
Q A method for masking bitter and astringent taste Natural extract [84, 85] 
R Identification of dual agonistic novel ligands for insulin receptor Acetate derivatives of gymnemic acids [86] 
S Treatment of dental caries 
Leaves 
- 
Methanol, chloroform, petrol ether 
[43] 
[39] 
T Effect on rumen fermentation, protozoa population and methanogenesis Leaves - [15] 
U Applications Natural extract [74-81] 
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Whole plants Aerial parts Leaves Roots 
Extract 
Entry 
H H E  
B B C  Water 
  S  
M H E  
 B G/O  Methanol 
  H  
 B E  
Ethanol 
  H/I  
Acetone  E G E 
Ethyl acetate     
 E G E 
Chloroform 
 B S  
Benzene     
Diethyl ether  E  E 
  S  
Petrol ether 
    
Hexane E B   
Pure saponin fraction   E/F/C/L  
 
Schema (1). Examined extracts of the different parts of GS and the relative biological activities. 
 
of GS have also been demonstrated to have significant anti-
bacterial and antiviral properties. GS can be taken in cap-
sules or as a herbal tea, and both modes appear to be equally 
effective. The intake of GS in the commonly used doses is no 
problem for adults and has been deemed very safe. In gen-
eral, the correct administration of phytotherapeutics poses no 
risk of toxicity. However, consumers should be aware of the 
potential toxicity of these products and understand that eve-
rything that is natural does not hurt. These products have 
their own pharmacology, and their effects and the risk of side 
effects increases when increasing the dose. In particular, for 
a medicinal plant such as GS, it would be interesting and 
useful to arrive at a precise definition of the fraction called 
gymnemic acid as well as to accurately delineate the full 
spectrum of its biological activities, which is a prerequisite 
for making its use even more extensive. In Table 3 and the 
schema 1 the biological activities of the examined extracts of 
the different parts of GS are reported schematically, but 
large-scale clinical trials have not been conducted to evaluate 
their safety and efficacy. 
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